Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Haaglanden Medical Centre (HMC) is a leading top-clinical hospital group located in the Hague region of the Netherlands. Formed by the merger of Medisch Centrum Haaglanden and Bronovo-Nebo, the organization operates three main facilities: HMC Westeinde, HMC Antoniushove, and HMC Bronovo. The center provides a comprehensive range of secondary and tertiary healthcare services, with specialized expertise in oncology, neuro-care, and emergency medicine. HMC Westeinde houses one of the busiest Level 1 trauma centers in the country, while HMC Antoniushove is recognized for its integrated cancer center. As a teaching hospital, HMC maintains significant academic collaborations, particularly with the Leiden University Medical Center (LUMC), to advance clinical research and medical education. The institution serves a diverse urban population, focusing on high-quality patient care and innovative medical treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Haaglanden Medical Centre.